Thus, it is likely that in ERBB2-positive and basal-like breast cancers, other drivers than CINSARC genes are prominently leading the metastatic process, while in Luminal A breast cancers estrogen receptor signaling plays a major role. This evidence concerns the gene ERBB2 and breast cancer.